Page last updated: 2024-08-17

mepazine and biperiden

mepazine has been researched along with biperiden in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Betzel, C; Bockhorn, M; Buchholz, A; El Gammal, AT; Graß, JK; Grupp, K; Güngör, C; Hofmann, BT; Izbicki, JR; Kapis, S; Klemp, C; Konczalla, L; Landschulze, D; Lüddeke, J; Meier, C; Nuguid, T; Perez, DR; Püschel, K; Sauter, G; Schumacher, U; Spriestersbach, SL; Steinberg, P; Uzunoglu, FG; Wenzel, N; Wolski, A; Wolters-Eisfeld, G; Yao, D1

Reviews

1 review(s) available for mepazine and biperiden

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

2 other study(ies) available for mepazine and biperiden

ArticleYear
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer.
    International journal of cancer, 2020, 03-15, Volume: 146, Issue:6

    Topics: Animals; Biperiden; Carcinoma, Pancreatic Ductal; Cell Growth Processes; Cell Line, Tumor; Humans; Mice; Mice, Knockout; Models, Molecular; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein; NF-kappa B; Pancreatic Neoplasms; Phenothiazines; Proto-Oncogene Proteins c-rel; Random Allocation; Xenograft Model Antitumor Assays

2020